SCD and hyperlipidemia: In people, both SCD-1 activity and plasma palmitoleic acid concentration are stimulated by carbohydrate excess and serve as key drivers for de novo lipogenesis and the hyperlipidemia associated with metabolic syndrome [20, 21].